Oncopeptides AB
Oncopeptides AB is a privately held clinical stage company developing melflufen, a peptidase potentiated therapy for multiple myeloma.
Information about Oncopeptides AB
Company Categories
Drug Manufacturing & Research, Multiple Myeloma, Pharmaceuticals, Melflufen, Healthcare, Plasma Cell Myeloma, Orphan Drug, Relapsed & Relapsed-Refractory Multiple Myeloma, Peptidase Potentiated, Anti-Angiogenic, Cytotoxicity, Alkylation, Peptidase Targeting, Phase II, Efficacy Studies, Oncology,Frequent questions about Oncopeptides AB
How many employees does Oncopeptides AB have?
What is Oncopeptides AB's industry?
Where is Oncopeptides AB headquarters located?
What is the website of Oncopeptides AB?
Other companies
HealthMetrics is a cloud-based enterprise HR solution to manage complex corporate medical benefits.
Pharmacy Consumerism and Transparency
At Green Mountain Coffee-«, a good quality coffee just isn't good enough.
Dieffenbacher is a manufacturer of press systems and production plants for the wood-based panels, composites and recycling industries.
Erasca creating a new generation of oncology drugs intended to not just treat, but actually cure Cancer.
Pairview is a professional services training company located in Canary Wharf.
Healthmonix platform is all-inclusive value-based payments solution for health systems, medical groups and payors.
MGM Grand Detroit is an entertainment center with a casino, hotel and a restaurant.
Paisabazaar.com is an online marketplace for all lending and investment products
Rx Mosaic Health is a PR company specializing in public relations campaigns.
Kendo does not guarantee or claim any of the information found on this public directory to be 100% accurate or up to date.Information found here is gathered from a variety of online and offline sources.
If you wish to exclude your personal data from this public directory send us an email to alex@kendoemailapp.com